Scott J. Cameron

This study shows that platelet PAR4 signaling, interacting with estrogen receptor beta, drives glioblastoma progression and immune suppression, with sex-specific effects on survival and TME dynamics.

This study shows that RGS6 inhibits platelet activation and arterial thrombosis by modulating P2Y12/Gi signaling in mice.

The paper identifies OR2L13 agonists that reduce platelet reactivity and thrombosis by depolymerizing the actin cytoskeleton through HSP27 phosphorylation.

This study shows that platelet inhibition increases rupture risk in early abdominal aortic aneurysm models in mice.

The paper shows that platelet receptor signaling differs between healthy men and women and changes after myocardial infarction, with implications for sex-specific anti-platelet therapy.